Kala Pharmaceuticals Shares Down 23% on Reverse Stock Split
marketwatch.com
news
2022-10-21 15:25:00

By Kathryn Hardison Shares of Kala Pharmaceuticals Inc. dropped 23%, to $7.72, on Friday after the company's shares began trading on a split-adjusted basis. Shares on Friday also reached an all-time intraday low of $7.50, according to FactSet. The biopharmaceutical company focused on therapies for eye diseases said Thursday it was implementing a reverse stock split at a ratio of 1 post-split share for every 50 pre-split shares. Trading on a split-adjusted basis began Friday when the market opened.
